More than half of Canadians will be diagnosed with a chronic illness in their lifetime

Every day, researchers at Mount Sinai Hospital are finding ways to improve the treatment of common, debilitating diseases and even prevent them from occurring in the first place.

Millions of Canadians are affected by cancer, diabetes, spinal cord injury, Parkinson’s disease, kidney disease, arthritis, osteoporosis and psychiatric illnesses. Since 1985, scientists at

Mount Sinai Hospital’s Samuel

Lunenfeld Research Institute have discovered innovative ways to improve the diagnosis, treatment and prevention of these illnesses, as well as unlock the secrets of what causes them in the first place. Researchers are drawn to the Lunenfeld from renowned scientific centres worldwide, seeking to learn from and partner with our experts who are putting Canada on the global map of discovery and innovation. The Lunenfeld is where you will find many of Canada’s brightest scientific minds who are working with Mount Sinai’s clinicians to lead some of the world’s largest clinical trial programs, which are currently reshaping medical care. Apersonalized approach to health care draws on these extraordinary advances in genetic knowledge and allows physicians to make more informed health decisions, intervene earlier in the course of a patient’s illness and tailor therapy to a patient’s unique genetic makeup. “Every day our researchers and clinicians come together to find innovative ways to deliver the best medicine to every one of our patients,” says Joseph Mapa, President and CEOOF Mount Sinai Hospital. Scientific discoveries that begin at the Lunenfeld today are bringing a healthier future to Canada and have already resulted in new and better ways to prevent, diagnose and treat common illnesses that impact the wellbeing of our families and communities.